Physician profile
Kole Akula
NPI 1326674029
$2,599.51
in general payments reported to CMS, 2019-2025
9 companies · $691 in 2025
The $691 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.07 · 2023: $998 · 2024: $833 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $897.94 | 2022-2025 | Ams 700, Advance Xp, General - Erectile Dysfunction |
| Medtronic, INC. | $781.30 | 2023-2024 | Interstim |
| Coloplast Corp | $522.92 | 2023-2025 | Speedicath |
| Janssen Biotech, INC. | $115.39 | 2024 | Erleada, Akeega |
| Antares Pharma, INC. | $100.62 | 2023 | Xyosted, Tlando |
| Ethicon US, LLC | $98.58 | 2024-2025 | Dermabond, Stratafix, Echelon; Endopath |
| Cook Medical LLC | $34.86 | 2024 | Resonance, Cook |
| Olympus America INC. | $26.06 | 2025 | Hd Camera Head |
| Endo USA, INC. | $21.84 | 2025 | Aveed, Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kole Akula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.